Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Utility of RET mutation analysis in multiple endocrine neoplasia type 2.

Archives of pathology & laboratory medicine - 1 Nov 1999

Noll W W

Abstract excerpt

OBJECTIVE: To review the role of RET mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) and in presymptomatic screening for this disorder. DATA SOURCES: Review of the medical literature and current clinical practice. CONCLUSIONS: RET mutation analysis is a sensitive and specific test for MEN 2. It plays a pivotal role in the diagnosis and management of patients and families with MEN...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Gland Neoplasms
Share to Genetic Counseling
Share to Multiple Endocrine Neoplasia Type 2a

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Pheochromocytoma

Share to Proto-Oncogene Proteins c-ret

Share to Proto-Oncogenes

Share to Receptor Protein-Tyrosine Kinases

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 10539905
DOI: 10.5858/1999-123-1047-UORMAI

Genes

RET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Utility of RET mutation analysis in multiple endocrine neoplasia type 2.PMID 10539905Read ↗

Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2.Semantic proximity Read ↗

RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.Semantic proximity Read ↗

RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma.Semantic proximity Read ↗

RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.Semantic proximity Read ↗

Molecular diagnosis of multiple endocrine neoplasia Type 2.Semantic proximity Read ↗

Multiple endocrine neoplasia type 2: A review.Semantic proximity Read ↗

Multiple endocrine neoplasia type 2: 2007 update.Semantic proximity Read ↗

Multiple endocrine neoplasia type 2.Semantic proximity Read ↗

[Multiple endocrine neoplasia type 2].Semantic proximity Read ↗

Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.Semantic proximity Read ↗

RET gene abnormalities and thyroid disease: who should be screened and when.Semantic proximity Read ↗

Molecular implications of RET mutations for pheochromocytoma risk in multiple endocrine neoplasia 2.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.